Page 47 - Recursion Pharmaceuticals News Today

(Bloomberg Businessweek) -- Even with catered lunches and two on-site gyms, Bryce Hunt has no interest in working full-time from software maker Podium Corp’s office in Lehi, Utah.

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...

The deployment of AI-driven drug discovery in areas such as oncology, neurology, and cardiology reduces gaps in R&D for improved drug...

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Utah biotech startup Recursion Pharmaceuticals on Tuesday announced a deal with Swiss drug and diagnostics giant Roche AG, and its U.S. subsidiary Genentech, that could generate billions in new revenues. Recursion has been on a roll in 2021, raising over $500 million in an April IPO and launching plans to more than double the size of its Salt Lake City headquarter facilities.

Biotech startup Recursion Pharmaceuticals on Tuesday announced a mega deal with Swiss drug and diagnostics giant Roche AG, and its U.S. subsidiary Genentech, that could generate billions in new revenues for the Salt Lake City-based company in the coming decade.

AI Medicine Software Market Trends to Keep an Eye On in 2022 | Enlitic, Atomwise, DeepMind

AI Medicine Software Market Trends to Keep an Eye On in 2022 | Enlitic, Atomwise, DeepMind

AI in Healthcare Market Is Booming Worldwide with Google, IBM, Microsoft, Sentrian

The deployment of AI-driven drug discovery in areas such as oncology, neurology, and cardiology reduces gaps in R&D for improved drug...